Literature DB >> 10866684

Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma.

J Niklinski1, G Claassen, C Meyers, M A Gregory, C J Allegra, F J Kaye, S R Hann, M Zajac-Kaye.   

Abstract

Somatic mutations at Thr-58 of c-Myc have been detected in Burkitt's lymphoma (BL) tumors and have been shown to affect the transforming potential of the Myc oncoprotein. In addition, the N-terminal domain of c-Myc has been shown to interact with microtubules in vivo, and the binding of c-Myc to alpha-tubulin was localized to amino acids 48 to 135 within the c-Myc protein. We demonstrate that c-Myc proteins harboring a naturally occurring mutation at Thr-58 from BL cell lines have increased stability and are constitutively hyperphosphorylated, which disrupts the in vivo interaction of c-Myc with alpha-tubulin. In addition, we show that wild-type c-Myc-alpha-tubulin interactions are also disrupted during a transient mitosis-specific hyperphosphorylation of c-Myc, which resembles the constitutive hyperphosphorylation pattern of Thr-58 in BL cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866684      PMCID: PMC85977          DOI: 10.1128/MCB.20.14.5276-5284.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

Review 1.  Myc-mediated transformation: the repression connection.

Authors:  G F Claassen; S R Hann
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

2.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  The transforming activity of the chicken c-myc gene can be potentiated by mutations.

Authors:  L Frykberg; T Graf; B Vennström
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

4.  Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.

Authors:  S R Hann; R N Eisenman
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

5.  Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.

Authors:  T H Rabbitts; P H Hamlyn; R Baer
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

6.  Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma.

Authors:  A ar-Rushdi; K Nishikura; J Erikson; R Watt; G Rovera; C M Croce
Journal:  Science       Date:  1983-10-28       Impact factor: 47.728

7.  Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.

Authors:  T H Rabbitts; A Forster; P Hamlyn; R Baer
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

8.  Activation of a translocated c-myc gene: role of structural alterations in the upstream region.

Authors:  K G Wiman; B Clarkson; A C Hayday; H Saito; S Tonegawa; W S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic.

Authors:  S Palmieri; P Kahn; T Graf
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  14 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  EBNA-LP associates with cellular proteins including DNA-PK and HA95.

Authors:  I Han; S Harada; D Weaver; Y Xue; W Lane; S Orstavik; B Skalhegg; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.

Authors:  Ai Kotani; Il-Mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Nasim A Begum; Toshiharu Nakajima; Hirohisa Saito; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

4.  Post-translational control of Myc function during differentiation.

Authors:  Maralice Conacci-Sorrell; Robert N Eisenman
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

5.  Myc-nick: the force behind c-Myc.

Authors:  Kambiz Mousavi; Vittorio Sartorelli
Journal:  Sci Signal       Date:  2010-12-14       Impact factor: 8.192

6.  A role for c-Myc in regulating anti-mycobacterial responses.

Authors:  Howard C H Yim; James C B Li; John C H Pong; Allan S Y Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-12       Impact factor: 11.205

7.  Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation.

Authors:  Maralice Conacci-Sorrell; Celine Ngouenet; Robert N Eisenman
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

8.  Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophages.

Authors:  Mohammad Asim; Rupesh Chaturvedi; Svea Hoge; Nuruddeen D Lewis; Kshipra Singh; Daniel P Barry; Holly S Algood; Thibaut de Sablet; Alain P Gobert; Keith T Wilson
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

9.  MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Authors:  Giuliana Gatti; Giovanna Maresca; Manuela Natoli; Fulvio Florenzano; Angelo Nicolin; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

10.  Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction.

Authors:  Ping-Jie Xiao; Angela M Mitchell; Lu Huang; Chengwen Li; R Jude Samulski
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.